Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Cancer Vaccine for Triple Negative Breast Cancer
Recruiting2 awardsPhase 2
Baltimore, Maryland
This trial studies the effect of a special vaccine called STEMVAC, given with sargramostim, in patients with a hard-to-treat type of breast cancer. The vaccine helps the immune system recognize and attack cancer cells. The goal is to see how well the immune system responds to this treatment. STEMVAC is a type of cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service